CMBN presented extensively on International Business Times web site
The Norwegian Centre for Molecular Biology and Neuroscience (CMBN) at the Oslo University Hospital and University of Oslo (UiO) was among the initial 13 Norwegian Centres of Excellence (SFF) established. After ten years, its activities as an SFF centre are drawing to a close. In connection with this, the centre has been extensively presented in an article published in the "Business and Health" section of the major online global newspaper "International Business Times", under the headline "Important brain discoveries". It is here pointed out that the centre's interdisciplinary research on DNA repair mechanisms in the brain is at the very forefront of the field.
From major journals, first or last author from the Institute for Cancer Research
Bergholtz H, Carter JM, Cesano A, Cheang MCU, Church SE, Divakar P, Fuhrman CA, Goel S, Gong J, Guerriero JL, Hoang ML, Hwang ES, Kuasne H, Lee J, Liang Y, Mittendorf EA, Perez J, Prat A, Pusztai L, Reeves JW, Riazalhosseini Y, Richer JK, Sahin √Ė, Sato H, Schlam Iet al.(2021) Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx¬ģ Digital Spatial Profiler Cancers (Basel), 13(17) DOI 10.3390/cancers13174456, PubMed 34503266
Taavitsainen S, Engedal N, Cao S, Handle F, Erickson A, Prekovic S, Wetterskog D, Tolonen T, Vuorinen EM, Kiviaho A, N√§tkin R, H√§kkinen T, Devlies W, Henttinen S, Kaarij√§rvi R, Lahnalampi M, Kaljunen H, Nowakowska K, Syv√§l√§ H, Bl√§uer M, Cremaschi P, Claessens F, Visakorpi T, Tammela TLJ, Murtola Tet al.(2021) Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse Nat Commun, 12(1), 5307 DOI 10.1038/s41467-021-25624-1, PubMed 34489465
M√łller P, Sampson JR, Dominguez-Valentin M, Sepp√§l√§ TT(2021) Towards evidence-based personalised precision medicine for Lynch syndrome Lancet Oncol, 22(9), e383 DOI 10.1016/S1470-2045(21)00400-9, PubMed 34478667
Krzyscik MA, Zakrzewska M, S√łrensen V, √ėy GF, Brunheim S, Haugsten EM, M√¶landsmo GM, Wiedlocha A, Otlewski J(2021) Fibroblast Growth Factor 2 Conjugated with Monomethyl Auristatin E Inhibits Tumor Growth in a Mouse Model Biomacromolecules(in press) DOI 10.1021/acs.biomac.1c00662, PubMed 34542998